INTUITIVE SURGICAL INC (IUI1.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:IUI1 - US46120E6023 - Common Stock
452.65 EUR
+5.2 (+1.16%)
We assign a fundamental rating of 6 out of 10 to IUI1. IUI1 was compared to 67 industry peers in the Health Care Equipment & Supplies industry. IUI1 gets an excellent profitability rating and is at the same time showing great financial health properties. IUI1 shows excellent growth, but is valued quite expensive already. These ratings would make IUI1 suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
- IUI1 had positive earnings in the past year.
- In the past year IUI1 had a positive cash flow from operations.
- In the past 5 years IUI1 has always been profitable.
- In the past 5 years IUI1 always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of IUI1 (14.19%) is better than 94.03% of its industry peers.
- IUI1's Return On Equity of 16.12% is amongst the best of the industry. IUI1 outperforms 83.58% of its industry peers.
- IUI1 has a better Return On Invested Capital (11.69%) than 82.09% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for IUI1 is in line with the industry average of 9.84%.
- The last Return On Invested Capital (11.69%) for IUI1 is above the 3 year average (9.53%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 11.69% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)9.53%
ROIC(5y)9.27%
1.3 Margins
- IUI1 has a better Profit Margin (28.58%) than 98.51% of its industry peers.
- IUI1's Profit Margin has declined in the last couple of years.
- With an excellent Operating Margin value of 29.44%, IUI1 belongs to the best of the industry, outperforming 98.51% of the companies in the same industry.
- IUI1's Operating Margin has declined in the last couple of years.
- With a decent Gross Margin value of 66.38%, IUI1 is doing good in the industry, outperforming 73.13% of the companies in the same industry.
- In the last couple of years the Gross Margin of IUI1 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IUI1 is still creating some value.
- The number of shares outstanding for IUI1 has been increased compared to 1 year ago.
- Compared to 5 years ago, IUI1 has more shares outstanding
- IUI1 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- IUI1 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.17
WACC10.02%
2.3 Liquidity
- A Current Ratio of 4.97 indicates that IUI1 has no problem at all paying its short term obligations.
- IUI1's Current ratio of 4.97 is amongst the best of the industry. IUI1 outperforms 95.52% of its industry peers.
- A Quick Ratio of 4.20 indicates that IUI1 has no problem at all paying its short term obligations.
- With an excellent Quick ratio value of 4.20, IUI1 belongs to the best of the industry, outperforming 95.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
- IUI1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.12%, which is quite impressive.
- IUI1 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
- Looking at the last year, IUI1 shows a very strong growth in Revenue. The Revenue has grown by 22.18%.
- IUI1 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.27% yearly.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
- The Earnings Per Share is expected to grow by 15.67% on average over the next years. This is quite good.
- The Revenue is expected to grow by 14.12% on average over the next years. This is quite good.
EPS Next Y20.12%
EPS Next 2Y16.35%
EPS Next 3Y15.9%
EPS Next 5Y15.67%
Revenue Next Year21.33%
Revenue Next 2Y18.13%
Revenue Next 3Y16.56%
Revenue Next 5Y14.12%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- IUI1 is valuated quite expensively with a Price/Earnings ratio of 61.50.
- IUI1's Price/Earnings ratio is a bit more expensive when compared to the industry. IUI1 is more expensive than 61.19% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.32. IUI1 is valued rather expensively when compared to this.
- IUI1 is valuated quite expensively with a Price/Forward Earnings ratio of 53.40.
- Based on the Price/Forward Earnings ratio, IUI1 is valued a bit more expensive than the industry average as 73.13% of the companies are valued more cheaply.
- IUI1 is valuated expensively when we compare the Price/Forward Earnings ratio to 24.32, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.5 | ||
| Fwd PE | 53.4 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IUI1 indicates a slightly more expensive valuation: IUI1 is more expensive than 67.16% of the companies listed in the same industry.
- IUI1's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 82.7 | ||
| EV/EBITDA | 52.02 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IUI1 does not grow enough to justify the current Price/Earnings ratio.
- IUI1 has an outstanding profitability rating, which may justify a higher PE ratio.
- IUI1's earnings are expected to grow with 15.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.06
PEG (5Y)5.36
EPS Next 2Y16.35%
EPS Next 3Y15.9%
5. Dividend
5.1 Amount
- IUI1 does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
INTUITIVE SURGICAL INC / IUI1.DE FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 6 / 10 to IUI1.DE.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (IUI1.DE). This can be considered as Overvalued.
Can you provide the profitability details for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (IUI1.DE) has a profitability rating of 8 / 10.
Can you provide the financial health for IUI1 stock?
The financial health rating of INTUITIVE SURGICAL INC (IUI1.DE) is 7 / 10.